68Ga-PSMA PET/MRI for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer
Phase of Trial: Phase II/III
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 11 Jun 2016 Status changed from not yet recruiting to recruiting.
- 20 May 2016 Planned primary completion date changed from 1 Feb 2021 to 1 Jun 2021.
- 20 May 2016 Planned initiation date changed from 1 Mar 2016 to 1 Jun 2016.